Team (TISI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
25 Nov, 2025Executive summary
Q1 2025 revenue was $198.7 million, essentially flat year-over-year, with IHT segment growth offset by MS segment decline and a gross margin of 23.8%.
Net loss widened to $29.7 million, including an $11.9 million loss on debt extinguishment from March 2025 refinancing.
Adjusted EBITDA was $5.3 million (2.7% of revenue), down from $6.5 million in the prior year quarter.
Operating performance and cash flow improvements enabled a successful refinancing in March 2025, extending maturities to 2030 and improving covenants.
Regained compliance with NYSE listing standards in March 2025.
Financial highlights
IHT segment revenue increased 6.8% year-over-year to $106.2 million, while MS segment revenue declined 7.7% to $92.4 million.
Gross margin was $47.3 million (23.8% of revenue), down from 24.4% in the prior year.
Adjusted net loss was $14.9 million, nearly flat compared to $14.7 million in Q1 2024.
Free cash flow was negative $30.1 million, compared to negative $1.1 million in the prior year.
Net loss per share was $6.61, compared to $3.89 in Q1 2024.
Outlook and guidance
Expects at least 15% year-over-year growth in Adjusted EBITDA for the full year 2025 and top-line growth in Q2.
Management expects current working capital, forecasted cash flows, and available credit to be sufficient for operations and debt service for at least the next twelve months.
Anticipates improved performance from Canadian and international operations and full-year impact of cost-saving initiatives in 2026.
Ongoing optimization program targeting at least $10 million in annualized cost savings.
Latest events from Team
- 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing24 Mar 2026 - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 20242 Feb 2026 - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 202415 Jan 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, and a charter amendment on director removal.TISI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Q2 revenue rose 8.5% to $248.0M, Adjusted EBITDA up 12.4%, with margin gains and transformation underway.TISI
Q2 202523 Nov 2025